Skip to main content
. 2019 Aug 21;12:2547–2553. doi: 10.2147/JPR.S214314

Table 1.

Patient characteristics

Patient Age, gender BMI Current smoking/Diabetes/Hypertention Bilateral occipital pain Average VAS pre-trial Analgesic medication used Other interventions prior to SCS Successful trial VAS after permanent implantation
#1 34.6, M 34.4 No/no/yes No 5.4 Gabapentin, oxycodone, venlafaxine, amitriptyline Failed ON stimulation trial No
#2 41, F 27.6 No/no/no No 5.7 Gabapentin, venlafaxine, nortriptyline, oxycodone Failed ON stimulation trial, nerve block No
#3 51, F 27.1 No/no/no No 5 Gabapentin, duloxetine, hydrocodone, rizatriptan Nerve block No
#4 57.7, F 35 No/no/no Yes 7.5 Gabapentin, hydromorphone, oxycodone Nerve block Yes 4
#5 29, F 28.6 No/no/no No 6.5 Tramadol, duloxetine hydrocodone Nerve block, occipital cryoablation Yes 5

Abbreviations: BMI, body mass index; ON, occipital nerve; SCS, spinal cord stimulation; VAS, visual analog scale.